BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9505081)

  • 1. [Cost-benefit principle and cost containment].
    Krauth C; Schwartz FW
    Med Klin (Munich); 1998 Jan; 93(1):49-51. PubMed ID: 9505081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care cost containment in the Federal Republic of Germany.
    Schneider M
    Health Care Financ Rev; 1991; 12(3):87-101. PubMed ID: 10113614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addressing government and market failures with payment incentives: Hospital reimbursement reform in Hainan, China.
    Yip W; Eggleston K
    Soc Sci Med; 2004 Jan; 58(2):267-77. PubMed ID: 14604613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rehabilitation from the economic viewpoint in relation to the legal social security insurance].
    Schliehe F
    Z Gerontol Geriatr; 1997 Dec; 30(6):456-68. PubMed ID: 9499488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does co-payment rate influence the relationship between monthly salary and health care service demand among the insured of health insurance societies in Japan?
    Lkhagva D; Gao Y; Babazono A
    Popul Health Manag; 2013 Feb; 16(1):58-63. PubMed ID: 22823294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sustainability of Canada's healthcare system: a framework for advancing the debate. Commentary.
    Lewis S
    Healthc Q; 2007; 10(2):103-4; author reply 105-6. PubMed ID: 18271107
    [No Abstract]   [Full Text] [Related]  

  • 7. The impact of nonreferral outpatient co-payment on medical care utilization and expenditures in Taiwan.
    Chen LC; Schafheutle EI; Noyce PR
    Res Social Adm Pharm; 2009 Sep; 5(3):211-24. PubMed ID: 19733822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards a social discount rate for the economic evaluation of health technologies in Germany: an exploratory analysis.
    Schad M; John J
    Eur J Health Econ; 2012 Apr; 13(2):127-44. PubMed ID: 21170731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What kind of health economics do we need?
    Lhachimi SK; Ostermann H
    Z Evid Fortbild Qual Gesundhwes; 2016; 110-111():18-20. PubMed ID: 26875030
    [No Abstract]   [Full Text] [Related]  

  • 10. Health care cost inflation and employer cost management.
    Custer WS
    J Occup Med; 1990 Dec; 32(12):1229-34. PubMed ID: 2127284
    [No Abstract]   [Full Text] [Related]  

  • 11. [Deficiencies in health care. Health services research--bridge between medical quality assurance and financing crisis].
    Kirschner K
    Herz; 2001 May; 26(3):233-6. PubMed ID: 11413804
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality of services and demand for health care in Nigeria: a multinomial probit estimation.
    Akin JS; Guilkey DK; Denton EH
    Soc Sci Med; 1995 Jun; 40(11):1527-37. PubMed ID: 7667657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intractable spastic cerebral palsy in children: a Dutch cost of illness study.
    Hoving MA; Evers SM; Ament AJ; van Raak EP; Vles JS;
    Dev Med Child Neurol; 2007 May; 49(5):397-8. PubMed ID: 17503555
    [No Abstract]   [Full Text] [Related]  

  • 14. [Not Available].
    Prokop A; Prokop J
    Z Orthop Unfall; 2017 Feb; 155(1):18-20. PubMed ID: 28249336
    [No Abstract]   [Full Text] [Related]  

  • 15. [Psychiatrists - gatekeepers guarding welfare state benefits?].
    Schomerus G; Spindler P; Bröker F
    Psychiatr Prax; 2005 May; 32(4):161-2. PubMed ID: 15852206
    [No Abstract]   [Full Text] [Related]  

  • 16. Containing health costs in the Americas.
    Márquez P
    Health Policy Plan; 1990; 5(4):299-315. PubMed ID: 10113451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Health care systems and aspects of health care economics. Sector ophthalmology - part 1: development of the German health care system].
    Kern T; Kohnen T
    Ophthalmologe; 2010 Nov; 107(11):1083-90; quiz 1090-1. PubMed ID: 21052680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care cost containment in West Germany.
    Stone DA
    J Health Polit Policy Law; 1979; 4(2):176-99. PubMed ID: 114573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of cost sharing of prescription drug expenditures on health care utilization by the elderly: own- and cross-price elasticities.
    Li X; Guh D; Lacaille D; Esdaile J; Anis AH
    Health Policy; 2007 Aug; 82(3):340-7. PubMed ID: 17134787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using Australian DRGs in Germany: a commentary.
    Hindle D; Lenz MJ
    Aust Health Rev; 2001; 24(1):136-47. PubMed ID: 11357728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.